{
    "clinical_study": {
        "@rank": "20170", 
        "arm_group": {
            "arm_group_label": "Hodgkin Lymphoma Survivor", 
            "description": "This is a prospective cross-sectional study of 200 HL survivors whose treatment included mediastinal RT at initial diagnosis or relapse, and are at least 5 years from last HL treatment."
        }, 
        "brief_summary": {
            "textblock": "This study will test whether cardiac MRI can improve early detection of Hodgkin lymphoma\n      associated heart disease compared to a stress echocardiogram. By doing both stress\n      echocardiography and cardiac MRI, we will compare the ability of the two tests to detect\n      heart disease."
        }, 
        "brief_title": "Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors", 
        "condition": "Hodgkin Lymphoma Survivor", 
        "condition_browse": {
            "mesh_term": [
                "Hodgkin Disease", 
                "Lymphoma", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Classical HL diagnosis treated at Memorial Sloan-Kettering Cancer Center.\n\n          -  Age > or = to 18 years at time of initial diagnosis.\n\n          -  Treatment for HL that included mediastinal RT at initial diagnosis or relapse.\n\n          -  >  or = to 5 years from last HL treatment.\n\n        Exclusion Criteria:\n\n          -  Primary HL diagnosis prior to 1980.\n\n          -  Additional mediastinal RT or subsequent cardiotoxic systemic therapy for secondary\n             malignant neoplasm.\n\n          -  Known CAD/CHF (defined as documented myocardial infarction, cardiac\n             revascularization, angiographic obstructive CAD, or decreased LV function [EF < 55%]\n             during prior clinical care).\n\n          -  Contraindication to MRI (i.e. pacemakers, defibrillators, or aneurysm clips, or other\n             implanted ferromagnetic objects), adenosine (i.e. asthma with active wheezing, second\n             or third degree heart block, recent use [within 7 days] of dipyridamole, known\n             adenosine hypersensitivity, unstable angina or myocardial infarction within 7 days),\n             or gadolinium (i.e. known hypersensitivity to gadolinium, advanced renal\n             insufficiency as defined by glomerular filtration rate <30 ml/min/1.73m^2).\n\n          -  Contraindication to exercise stress testing other than the above (i.e. unstable\n             angina or severe valvular stenosis)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "MSKCC"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02106611", 
            "org_study_id": "14-017"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hodgkin Lymphoma Survivor", 
                "description": "HL treatment will be determined by review of available medical records as archived at MSKCC. Recorded variables will include: (1) RT - field, fractional and cumulative dose, and duration; (2) chemotherapy - regimen, planned interval, dose per cycle, and cumulative dosages.", 
                "intervention_name": "Clinical Assessment", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Hodgkin Lymphoma Survivor", 
                "description": "Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.", 
                "intervention_name": "Stress cardiac MRI", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Hodgkin Lymphoma Survivor", 
                "description": "Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.", 
                "intervention_name": "Stress echocardiogram", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "MRI", 
            "stress echo", 
            "Clinical Assessment", 
            "14-017"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "link": {
            "description": "Memorial Sloan Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": {
            "contact": {
                "last_name": "Matthew Matasar, MD", 
                "phone": "212-639-8889"
            }, 
            "contact_backup": {
                "email": "weinsafj@mskcc.org", 
                "last_name": "Jonathan Weinsaft, MD"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Memorial Sloan Kettering Cancer Center"
            }, 
            "investigator": {
                "last_name": "Matthew Matasar, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors", 
        "overall_contact": {
            "last_name": "Matthew Matasar, MD", 
            "phone": "212-639-8889"
        }, 
        "overall_contact_backup": {
            "email": "weinsafj@mskcc.org", 
            "last_name": "Jonathan Weinsaft, MD"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Matthew Matasar, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "detected by cardiac MRI to that detected by stress echocardiography among a broadly representative cohort of Hodgkin lymphoma survivors.", 
            "measure": "compare the prevalence of cardiac injury", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02106611"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}